Original Literature | Model OverView |
---|---|
Publication
Title
What is disrupting IFN-alpha's antiviral activity?
Affiliation
Infectious Diseases Research, Centocor, 200 Great Valley Parkway, R-4-1,Malvern, PA 19087, USA.
Abstract
Despite advances in treatment strategies for hepatitis C virus (HCV), asignificant proportion of patients fail to achieve viral clearance followingtreatment with pegylated interferon (IFN)-alpha plus ribavirin. Many of theseindividuals show elevated levels of tumor necrosis factor (TNF)-alpha comparedwith normal controls, and recent data have implicated this cytokine in thenegative regulation of IFN-alpha. Although a therapeutic opportunity forTNF-alpha antagonists might exist for reducing inflammation in chronic HCVdisease, further exploration is required to identify the key mediators ofresponsiveness to IFN-alpha. In particular, the interplay should be clarifiedbetween host response factors [e.g. IFN-alpha, IFN-gamma, suppressor of cytokinesignaling (SOCS), TNF-alpha and others] and pathogen-associated molecularpatterns [PAMPs, e.g. lipopolysaccharide (LPS) and CpG DNA] in HCV disease; thisinformation might guide future therapies aimed at improving IFN-alpharesponsiveness.
PMID
15283983
|
Entity
Process
SOCS1
--
G010539
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93501
0
infinite
0
TRANSFAC | G010539 |
--
SOCS3
--
G011948
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m94757
0
infinite
0
TRANSFAC | G011948 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
0
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
0
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
PKR
--
MO000008179
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1055
0
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000008179 |
--
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
0
infinite
0
TRANSPATH | MO000016882 |
--
IL-10
--
MO000017247
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2103
0
infinite
0
InterPro | IPR000098 |
TRANSPATH | MO000017247 |
--
IL-10R
--
MO000017252
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2108
0
infinite
0
TRANSPATH | MO000017252 |
--
IL-6R
--
MO000018458
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3096
0
infinite
0
InterPro | IPR003961 |
TRANSPATH | MO000018458 |
--
TLR4
--
MO000019394
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3961
0
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019394 |
--
TLR9
--
MO000042012
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19828
0
infinite
0
TRANSPATH | MO000042012 |
--
CBP
--
MO000099682
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m72733
0
infinite
0
TRANSPATH | MO000099682 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
IFNA:IFNAR
--
e10
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m10
0
infinite
0
--
Il-8
--
e11
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m11
0
infinite
0
--
Il-1
--
e12
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m12
0
infinite
0
--
TNF-alphaR
--
e13
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m13
0
infinite
0
--
TNF-alpha:recpetor
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m14
0
infinite
0
--
shp2
--
e15
cso30:c:mRNA
cso30:i:CC_Nucleolus
--
csml-variable:Double
m15
0
infinite
0
--
NS5A
--
e16
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m16
0
infinite
0
--
NS5A:PKR
--
e17
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m17
0
infinite
0
--
JAKs
--
e18
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m18
0
infinite
0
--
IFNA:IFNAR:JAK
--
e19
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
STAT
--
e20
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m20
0
infinite
0
--
STAT{p}
--
e21
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m21
0
infinite
0
--
STAT{p}
--
e22
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m22
0
infinite
0
--
ISGs
--
e23
cso30:c:Dna
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m23
0
infinite
0
--
DNA:STAT{p}
--
e24
cso30:c:Complex
cso30:i:CC_NuclearEnvelopeLumen
--
csml-variable:Double
m24
0
infinite
0
--
mRNA
--
e25
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m25
0
infinite
0
--
IFN-alpha
--
e26
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m26
0
infinite
0
--
HCV E2
--
e27
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m27
0
infinite
0
--
HCV E2:PKR {inactive}
--
e28
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m28
0
infinite
0
--
SOCS3
--
e29
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IFNAR:JAK:SOCS3
--
e30
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m30
0
infinite
0
--
SHP2
--
e31
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m31
0
infinite
0
--
IFNAR:JAK:SHP2
--
e32
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m32
0
infinite
0
--
csml-variable:Double
m33
0
infinite
0
--
csml-variable:Double
m34
0
infinite
0
--
IRF-3:CBP
--
e35
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m35
0
infinite
0
--
p300
--
e36
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m36
0
infinite
0
--
IRF-3:p300
--
e37
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m37
0
infinite
0
--
SOCS1
--
e38
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m38
0
infinite
0
--
IFNAR:JAK:SOCS1
--
e39
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
HCV core
--
e40
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m40
0
infinite
0
--
LPS:TLR4
--
e41
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m41
0
infinite
0
--
csml-variable:Double
m42
0
infinite
0
--
CpGDNA:TLR9
--
e43
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m43
0
infinite
0
--
IL-6:IL-6R
--
e44
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m44
0
infinite
0
--
Il-6:IL-6R:JAKs
--
e45
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m45
0
infinite
0
--
IL-10:IL-10R
--
e46
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m46
0
infinite
0
--
Il-10:IL-10R:JAKs
--
e47
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m47
0
infinite
0
--
IFNalpha
--
e5
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IFNAR
--
e6
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m6*m5*0.1
nodelay
--
0
PMID: 15283983,9041265,8591843 IFN-a also confers immunomodulatory benefits. For example, binding to its cognate cell-surface receptor on immune cells can result in: a reduction in inflammation by inhibiting production of IL-1, IL-8 and tumor necrosis factor (TNF)-a
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m14*0.1
nodelay
--
0
PMID: 15283983 TNF-a stimulates expression of SOCS3 and SHP2, which bind to the JAK ?IFN receptor complex.
p100
p100
cso30:i:ME_UnknownProduction
cso30:i:CC_Extracellular
--
--
--
p101
p101
cso30:i:ME_UnknownProduction
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
p102
p102
cso30:i:ME_UnknownProduction
cso30:i:CC_Extracellular
--
--
--
p103
p103
cso30:i:ME_UnknownProduction
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
--
p105
p105
cso30:i:ME_UnknownProduction
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
--
--
--
and
connectorcustom
--
1.0
--
0
--
p109
p109
cso30:i:ME_UnknownProduction
cso30:i:CC_Extracellular
--
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m16*m1055*0.1
nodelay
--
0
PMID: 15283983 NS5A binds to PKR in a region that overlaps the ISDR domain, and would be expected to suppress its function in vivo.
p110
p110
cso30:i:ME_UnknownProduction
cso30:i:CC_Extracellular
--
--
--
--
p112
p112
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytoplasm
--
--
--
p113
p113
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytoplasm
--
--
--
p114
p114
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytoplasm
--
--
--
--
--
--
--
--
p12
p12
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c54 : 1
stoichiometry:c60 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c34 : 1
m19*m20*0.1
nodelay
--
0
PMID:15283983 Specifically, the signal transducer and activator of transcription (STAT) family of latent cytoplasmic transcription factors become tyrosine phosphorylated by the Janus family of tyrosine kinases (JAK) following binding of IFNs to their cognate multi-subunit transmembrane receptor PMID:15283983 This interaction prevents STAT activation and translocation to the nucleus, where it would otherwise induce antiviral response genes containing an ISRE. PMID: 15283983,9857039,11427497 treatment ofcultured mammalian cells with IFN-a or TNF-a results in induction of SOCS1 and SOCS3, the only two SOCS proteins reported to inhibit IFN-mediated antiviral and antiproliferative activities PMID: 15283983,12551851 Consistent with this observation, an initial report by Bode et al. claimed that overexpression of the HCV core protein inhibits IFN-a-induced tyrosine phosphorylation and activation of STAT1 in hepatic cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
1.0*0.1
nodelay
--
0
--
--
p122
p122
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytoplasm
--
--
--
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m18*m10*0.1
nodelay
--
0
PMID: 15283983 TNF-a stimulates expression of SOCS3 and SHP2, which bind to the JAK ?IFN receptor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m21*0.1
nodelay
--
0
PMID:15283983 This interaction prevents STAT activation and translocation to the nucleus, where it would otherwise induce antiviral response genes containing an ISRE.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m22*m23*0.1
nodelay
--
0
PMID: 15283983 Specifically, they (STAT) recognize DNA promoter elements to modulate type I IFN (IFN-a and IFN-b) genes selectively, and also recognize the interferon-stimulated response element (ISRE) in some ISGs, leading to induction of an antiviral state. PMID:15283983 This interaction prevents STAT activation and translocation to the nucleus, where it would otherwise induce antiviral response genes containing an ISRE.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m24*0.1
nodelay
--
0
PMID: 15283983 Specifically, they (STAT) recognize DNA promoter elements to modulate type I IFN (IFN-a and IFN-b) genes selectively, and also recognize the interferon-stimulated response element (ISRE) in some ISGs, leading to induction of an antiviral state. PMID:15283983 This interaction prevents STAT activation and translocation to the nucleus, where it would otherwise induce antiviral response genes containing an ISRE.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m22*0.1
nodelay
--
0
PMID: 15283983 Specifically, they (STAT) recognize DNA promoter elements to modulate type I IFN (IFN-a and IFN-b) genes selectively, and also recognize the interferon-stimulated response element (ISRE) in some ISGs, leading to induction of an antiviral state.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m22*0.1
nodelay
--
0
PMID: 15283983 Specifically, they (STAT) recognize DNA promoter elements to modulate type I IFN (IFN-a and IFN-b) genes selectively, and also recognize the interferon-stimulated response element (ISRE) in some ISGs, leading to induction of an antiviral state.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m1055*m27*0.1
nodelay
--
0
PMID: 15283983 Similar to NS5A, the HCV E2 protein was reported to contain a double-stranded (ds)RNA-activated protein kinase eukaryotic initiation factor 2a (PKR-eIF2a) homology domain, which might be capable of interacting with and inactivating PKR.
p2
p2
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c10 : 1
stoichiometry:c7 : 1
m93309*0.1
nodelay
--
0
PMID: 15283983,9041265,8591843 IFN-a also confers immunomodulatory benefits. For example, binding to its cognate cell-surface receptor on immune cells can result in: a reduction in inflammation by inhibiting production of IL-1, IL-8 and tumor necrosis factor (TNF)-a
--
and
mass
coefficient1:0.01
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m94757*0.01
nodelay
--
0
PMID: 15283983 TNF-a stimulates expression of SOCS3 and SHP2, which bind to the JAK ?IFN receptor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m19*m29*0.1
nodelay
--
0
PMID: 15283983 TNF-a stimulates expression of SOCS3 and SHP2, which bind to the JAK ?IFN receptor complex.
--
and
mass
coefficient1:0.01
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m15*0.01
nodelay
--
0
PMID: 15283983 TNF-a stimulates expression of SOCS3 and SHP2, which bind to the JAK ?IFN receptor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m31*m19*0.1
nodelay
--
0
PMID: 15283983 TNF-a stimulates expression of SOCS3 and SHP2, which bind to the JAK ?IFN receptor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c110 : 1
stoichiometry:c63 : 1
m33*m48*0.1
nodelay
--
0
PMID: 15283983,10048763 Characterization of IRF-3 showed regulatory activity by binding to the ISRE of ISG15 and interaction with the CBP/p300 coactivator
p25
p25
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m977*m72733*0.1
nodelay
--
0
PMID: 15283983,10048763 Characterization of IRF-3 showed regulatory activity by binding to the ISRE of ISG15 and interaction with the CBP/p300 coactivator
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m977*m36*0.1
nodelay
--
0
PMID: 15283983,10048763 Characterization of IRF-3 showed regulatory activity by binding to the ISRE of ISG15 and interaction with the CBP/p300 coactivator
--
and
mass
coefficient1:0.01
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m93501*0.01
nodelay
--
0
PMID: 15283983,9857039,11427497 treatment ofcultured mammalian cells with IFN-a or TNF-a results in induction of SOCS1 and SOCS3, the only two SOCS proteins reported to inhibit IFN-mediated antiviral and antiproliferative activities
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m38*m19*0.1
nodelay
--
0
PMID: 15283983,9857039,11427497 treatment ofcultured mammalian cells with IFN-a or TNF-a results in induction of SOCS1 and SOCS3, the only two SOCS proteins reported to inhibit IFN-mediated antiviral and antiproliferative activities
p29
p29
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 15283983,14644140,10453004,11390452,12433373 SOCS1 and SOCS3 expression can be induced by various cytokines, and can also be induced by, and negatively regulate, LPS and CpG DNA, which are conserved bacterial components characterized as structural correlates of PAMP
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c11 : 1
stoichiometry:c8 : 1
m11*0.1
nodelay
--
0
PMID: 15283983,9041265,8591843 IFN-a also confers immunomodulatory benefits. For example, binding to its cognate cell-surface receptor on immune cells can result in: a reduction in inflammation by inhibiting production of IL-1, IL-8 and tumor necrosis factor (TNF)-a
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m41*0.1
nodelay
--
0
PMID: 15283983,14644140,10453004,11390452,12433373 SOCS1 and SOCS3 expression can be induced by various cytokines, and can also be induced by, and negatively regulate, LPS and CpG DNA, which are conserved bacterial components characterized as structural correlates of PAMP
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m41*0.1
nodelay
--
0
PMID: 15283983,14644140,10453004,11390452,12433373 SOCS1 and SOCS3 expression can be induced by various cytokines, and can also be induced by, and negatively regulate, LPS and CpG DNA, which are conserved bacterial components characterized as structural correlates of PAMP
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c84 : 1
m43*0.1
nodelay
--
0
PMID: 15283983,14644140,10453004,11390452,12433373 SOCS1 and SOCS3 expression can be induced by various cytokines, and can also be induced by, and negatively regulate, LPS and CpG DNA, which are conserved bacterial components characterized as structural correlates of PAMP
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c85 : 1
m43*0.1
nodelay
--
0
PMID: 15283983,14644140,10453004,11390452,12433373 SOCS1 and SOCS3 expression can be induced by various cytokines, and can also be induced by, and negatively regulate, LPS and CpG DNA, which are conserved bacterial components characterized as structural correlates of PAMP
p29
p34
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m42*m19828*0.1
nodelay
--
0
PMID: 15283983,14644140,10453004,11390452,12433373 SOCS1 and SOCS3 expression can be induced by various cytokines, and can also be induced by, and negatively regulate, LPS and CpG DNA, which are conserved bacterial components characterized as structural correlates of PAMP
p35
p35
cso30:i:ME_UnknownProduction
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c93 : 1
m3096*m871*0.1
nodelay
--
0
PMID: 15283983,14630206 This same pathway can be induced by activation of other cytokine receptors including those for IL-6 and IL-10
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m44*m18*0.1
nodelay
--
0
PMID: 15283983,14630206 This same pathway can be induced by activation of other cytokine receptors including those for IL-6 and IL-10
p37
p37
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c115 : 1
stoichiometry:c99 : 1
m45*m20*0.1
nodelay
--
0
PMID: 15283983,14630206 This same pathway can be induced by activation of other cytokine receptors including those for IL-6 and IL-10
p35
p38
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m2103*m2108*0.1
nodelay
--
0
PMID: 15283983,14630206 This same pathway can be induced by activation of other cytokine receptors including those for IL-6 and IL-10
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m46*m18*0.1
nodelay
--
0
PMID: 15283983,14630206 This same pathway can be induced by activation of other cytokine receptors including those for IL-6 and IL-10
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c12 : 1
stoichiometry:c9 : 1
m12*0.1
nodelay
--
0
PMID: 15283983,9041265,8591843 IFN-a also confers immunomodulatory benefits. For example, binding to its cognate cell-surface receptor on immune cells can result in: a reduction in inflammation by inhibiting production of IL-1, IL-8 and tumor necrosis factor (TNF)-a
p37
p40
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c111 : 1
stoichiometry:c114 : 1
stoichiometry:c116 : 1
stoichiometry:c108 : 1
m47*m20*0.1
nodelay
--
0
PMID: 15283983,14630206 This same pathway can be induced by activation of other cytokine receptors including those for IL-6 and IL-10
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c109 : 1
m977*0.1
nodelay
--
0
PMID: 15283983,10048763 Characterization of IRF-3 showed regulatory activity by binding to the ISRE of ISG15 and interaction with the CBP/p300 coactivator
p42
p42
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
--
p43
p43
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
--
p44
p44
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
p45
p45
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
p46
p46
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
p47
p47
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
--
p49
p49
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m230*m13*0.1
nodelay
--
0
PMID:15283983,9857039,11427497 treatment ofcultured mammalian cells with IFN-a or TNF-a results in induction of SOCS1 and SOCS3
--
--
p52
p52
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
p53
p53
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
p54
p54
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
p55
p55
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
--
p56
p56
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
p57
p57
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
--
p58
p58
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
--
p59
p59
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m14*0.1
nodelay
--
0
PMID:15283983,9857039,11427497 treatment ofcultured mammalian cells with IFN-a or TNF-a results in induction of SOCS1 and SOCS3
p60
p60
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
p61
p61
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
--
p63
p63
cso30:i:ME_UnknownDegradation
cso30:i:CC_Extracellular
--
--
--
p64
p64
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
--
--
p67
p67
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
p68
p68
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m14*0.1
nodelay
--
0
PMID: 15283983 TNF-a stimulates expression of SOCS3 and SHP2, which bind to the JAK ?IFN receptor complex.
--
--
--
--
--
--
p76
p76
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytoplasm
--
--
--
--
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m10*0.1
nodelay
--
0
PMID:15283983,9857039,11427497 treatment ofcultured mammalian cells with IFN-a or TNF-a results in induction of SOCS1 and SOCS3
--
--
--
--
--
--
--
--
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m10*0.1
nodelay
--
0
PMID:15283983,9857039,11427497 treatment ofcultured mammalian cells with IFN-a or TNF-a results in induction of SOCS1 and SOCS3
--
--
--
--
p94
p94
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytoplasm
--
--
--
--
--
--
p98
p98
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytoplasm
--
--
--
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--